These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22745830)

  • 1. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.
    Gui D; Guo Y; Wang F; Liu W; Chen J; Chen Y; Huang J; Wang N
    PLoS One; 2012; 7(6):e39824. PubMed ID: 22745830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
    Chen Y; Gui D; Chen J; He D; Luo Y; Wang N
    Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.
    Lei X; Zhang L; Li Z; Ren J
    Drug Des Devel Ther; 2018; 12():2785-2793. PubMed ID: 30233141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside suppresses apoptosis of the podocytes in rats with diabetic nephropathy via miR-378/TRAF5 signaling pathway.
    Lei X; Zhang BD; Ren JG; Luo FL
    Life Sci; 2018 Aug; 206():77-83. PubMed ID: 29792879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression.
    Gui D; Huang J; Guo Y; Chen J; Chen Y; Xiao W; Liu X; Wang N
    Cytokine; 2013 Mar; 61(3):970-7. PubMed ID: 23434274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6.
    Yao XM; Liu YJ; Wang YM; Wang H; Zhu BB; Liang YP; Yao WG; Yu H; Wang NS; Zhang XM; Peng W
    Mol Med Rep; 2016 Jun; 13(6):5149-56. PubMed ID: 27109610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
    Guo H; Wang Y; Zhang X; Zang Y; Zhang Y; Wang L; Wang H; Wang Y; Cao A; Peng W
    Sci Rep; 2017 Jul; 7(1):6852. PubMed ID: 28761152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of silencing Stat1 on high glucose-induced podocytes injury via Forkhead transcription factor O1-regulated the oxidative stress response.
    Wang H; Zhang Y; Xia F; Zhang W; Chen P; Yang G
    BMC Mol Cell Biol; 2019 Jul; 20(1):27. PubMed ID: 31337338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS.
    Sun LN; Liu XC; Chen XJ; Guan GJ; Liu G
    Acta Pharmacol Sin; 2016 May; 37(5):645-55. PubMed ID: 26838071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect and mechanism of catalpol on high glucose-induced podocyte injury.
    Chen Y; Liu Q; Shan Z; Zhao Y; Li M; Wang B; Zheng X; Feng W
    BMC Complement Altern Med; 2019 Sep; 19(1):244. PubMed ID: 31488111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats.
    Riedl E; Pfister F; Braunagel M; Brinkkötter P; Sternik P; Deinzer M; Bakker SJ; Henning RH; van den Born J; Krämer BK; Navis G; Hammes HP; Yard B; Koeppel H
    Cell Physiol Biochem; 2011; 28(2):279-88. PubMed ID: 21865735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy.
    Cui FQ; Tang L; Gao YB; Wang YF; Meng Y; Shen C; Shen ZL; Liu ZQ; Zhao WJ; Liu WJ
    J Diabetes Res; 2019; 2019():2981705. PubMed ID: 31179339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV prevents kidney injury caused by iatrogenic hyperinsulinemia in a streptozotocin‑induced diabetic rat model.
    He KQ; Li WZ; Chai XQ; Yin YY; Jiang Y; Li WP
    Int J Mol Med; 2018 Feb; 41(2):1078-1088. PubMed ID: 29207011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylsulfate-induced oxidative stress and mitochondrial dysfunction in podocytes are ameliorated by Astragaloside IV activation of the SIRT1/PGC1α /Nrf1 signaling pathway.
    Li L; Zou J; Zhou M; Li H; Zhou T; Liu X; Huang Q; Yang S; Xiang Q; Yu R
    Biomed Pharmacother; 2024 Aug; 177():117008. PubMed ID: 38901196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitic Acid-Induced Podocyte Apoptosis via the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Liu T; Chen XM; Sun JY; Jiang XS; Wu Y; Yang S; Huang HZ; Ruan XZ; Du XG
    Kidney Blood Press Res; 2018; 43(1):206-219. PubMed ID: 29490300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
    Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
    Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.